Treatment Outcomes after Discontinuation of Ethambutol due to Adverse Events in<i>Mycobacterium avium</i>Complex Lung Disease

Abstract

These findings suggest that treatment outcomes are unsatisfactory in patients with MAC-LD who discontinue EMB owing to adverse events. Notably, there was a statistically significant high failure rate in patients who were prescribed fluoroquinolone to replace EMB.